Clinical trial

A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension

NCT00150267

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention Xalacom Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-02-01

PhasePHASE3

Conditions

Glaucoma, Open-Anglecandidate · MONDO: open-angle glaucoma

Ocular Hypertensionverified · MONDO: ocular hypertension

Interventions

XalacomDRUG

Sponsors & collaborators

Pfizerlead sponsor

Mapped research locations

MainzGermany2 SydneyNew South Wales, Australia2 LondonUnited Kingdom1 ParisFrance1 MilanItaly1 MarseilleFrance1 BrusselsBelgium1 LeuvenBelgium1 StockholmSweden1 AthensGreece1 DijonFrance1 GhentBelgium1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00150267 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.